PL446307A1 - Scaffold, sposób jego uzyskiwania oraz zastosowania - Google Patents
Scaffold, sposób jego uzyskiwania oraz zastosowaniaInfo
- Publication number
- PL446307A1 PL446307A1 PL446307A PL44630723A PL446307A1 PL 446307 A1 PL446307 A1 PL 446307A1 PL 446307 A PL446307 A PL 446307A PL 44630723 A PL44630723 A PL 44630723A PL 446307 A1 PL446307 A1 PL 446307A1
- Authority
- PL
- Poland
- Prior art keywords
- scaffold
- medicine
- application
- tissue
- obtaining
- Prior art date
Links
- 239000003814 drug Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0613—Cells from endocrine organs
- C12N5/0617—Thyroid and parathyroid glands
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Przedmiotem zgłoszenia jest zdecelularyzowana macierz uzyskana z tkanki tarczycy, mająca postać pozbawionego komórek rusztowania komórkowego (tzw. scaffold) oraz sposób jej otrzymywania. Uzyskany materiał ze względu na swoje unikalne właściwości powinien znaleźć zastosowanie w medycynie, zwłaszcza regeneracyjnej oraz inżynierii tkankowej.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL446307A PL446307A1 (pl) | 2023-10-05 | 2023-10-05 | Scaffold, sposób jego uzyskiwania oraz zastosowania |
| PCT/PL2024/050072 WO2025075517A1 (en) | 2023-10-05 | 2024-10-07 | Scaffold, method for obtaining it and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL446307A PL446307A1 (pl) | 2023-10-05 | 2023-10-05 | Scaffold, sposób jego uzyskiwania oraz zastosowania |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL446307A1 true PL446307A1 (pl) | 2025-04-07 |
Family
ID=93741442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL446307A PL446307A1 (pl) | 2023-10-05 | 2023-10-05 | Scaffold, sposób jego uzyskiwania oraz zastosowania |
Country Status (2)
| Country | Link |
|---|---|
| PL (1) | PL446307A1 (pl) |
| WO (1) | WO2025075517A1 (pl) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019220091A1 (en) * | 2018-05-14 | 2019-11-21 | Ucl Business Ltd | Methods for tissue decellularization |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017136786A1 (en) * | 2016-02-05 | 2017-08-10 | The Trustees Of Columbia University In The City Of New York | Rigionally specific tissua-derived extracellular metrix |
| JP7470709B2 (ja) * | 2019-03-21 | 2024-04-18 | ミロマトリックス メディカル インコーポレイテッド | 摘出臓器又はその一部を脱細胞化する方法 |
-
2023
- 2023-10-05 PL PL446307A patent/PL446307A1/pl unknown
-
2024
- 2024-10-07 WO PCT/PL2024/050072 patent/WO2025075517A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019220091A1 (en) * | 2018-05-14 | 2019-11-21 | Ucl Business Ltd | Methods for tissue decellularization |
Non-Patent Citations (3)
| Title |
|---|
| JIE WENG, BI CHEN, MENGYING XIE I IN.,: "BioMed Eng OnLine, 2021, 20:18,", RABBIT THYROID EXTRACELLULAR MATRIX AS A 3D BIOSCAFFOLD FOR THYROID BIOENGINEERING: A PRELIMINARY IN VITRO STUDY, DOI: https://doi.org/10.1186/s12938-021-00856-w * |
| JUN PAN, HUI LI, YUN FANG, YI-BIN SHEN I IN.,: "Thyroid, 2019, 29:1, 142-152", REGENERATION OF A BIOENGINEERED THYROID USING DECELLULARIZED THYROID MATRIX,, DOI: https://doi.org/10.1089/thy.2018.0068 * |
| MCINNES, A.D.; MOSER, M.A.J.; CHEN, X.: "J. Funct. Biomater., 2022, 13, 240", PREPARATION AND USE OF DECELLULARIZED EXTRACELLULAR MATRIX FOR TISSUE ENGINEERING., DOI: https://doi.org/10.3390/jfb13040240 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025075517A1 (en) | 2025-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR042934A1 (es) | Composiciones de cemento con propiedades mecanicas mejoradas y metodo de cementacion en formaciones subterraneas | |
| MX2016000796A (es) | Composiciones de cemento portland de fraguado rapido con citratos fosfatos de metal alcalino y con alta resistencia a la compresion en fase inicial y contraccion reducida. | |
| GT200000141A (es) | Material cementoso extruible. | |
| MX2024011550A (es) | Acido retardante monofasico a base de un tensioactivo anfotero | |
| AR043968A1 (es) | Oxido nitrico en el tratamiento de inflamacion | |
| MX2022012740A (es) | Composicion de fragancia. | |
| FR826179A (fr) | Procédé de fabrication d'appareils médicaux de prothèse, notamment d'appareils de prothèse dentaire | |
| PL446307A1 (pl) | Scaffold, sposób jego uzyskiwania oraz zastosowania | |
| UY39744A (es) | Composición farmacéutica que comprende un agonista de gpr40 y un inhibidor de sglt-2 | |
| CO2023013308A2 (es) | Composición líquida que comprende un neonictonoide | |
| ES2182526T3 (es) | Metodo para mejorar las propiedades ingenieriles del suelo. | |
| ES2035859T3 (es) | Composicion abrillantadora para pisos. | |
| AR127094A1 (es) | Cemento mejorado con dióxido de carbono | |
| ES2014518A6 (es) | Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada. | |
| MX2023009825A (es) | Composicion y metodo de elaboracion de grasas a base de sulfonato utilizando un derivado de glicerol. | |
| MX2024009526A (es) | Formulación líquida que comprende una proteína de fusión que incluye a-galactosidasa a | |
| CL2023002683A1 (es) | Estructura de matriz para composición detergente ropa, composición sólida detergente, proceso productor detergente, uso celulosa | |
| AR127494A1 (es) | Formulación agroquímica de cera micronizada y silicona | |
| CL2023000450A1 (es) | Nueva composición de anticonceptivo oral de liberación modificada | |
| MX2024002865A (es) | Composicion que contiene cariofileno. | |
| AR022852A1 (es) | Nuevos androgenos | |
| MX2022004368A (es) | Formulacion de mezclas insecticidas que comprenden disolventes de eter de glicol. | |
| PL442989A1 (pl) | Materiał kompozytowy do implantacji zawierający hydroksyapatyt oraz sposób jego wytwarzania | |
| AR132274A1 (es) | Material cementante suplementario y método de fabricación del mismo | |
| PL447631A1 (pl) | Implant stomatologiczny podokostnowy |